Synthetic cannabinoid use in a psychiatric patient population: a pilot study
Salvato in:
Welter, S., et al., Synthetic cannabinoid use in a psychiatric patient population: a pilot study. European Addiction Research, vol. 23, n. 4, 2017, p. 182-197.
Ref.
528108
Localizzazione:
SIIS R.1142
Palabras clave:
Drogodependencias, Enfermedades mentales, Diagnóstico dual, Drogas ilegales, Cannabis, Efectos, Factor de riesgo, Psicosis
Drogodependencias, Enfermedades mentales, Diagnóstico dual, Drogas ilegales, Cannabis, Efectos, Factor de riesgo, Psicosis
Documenti analoghi: Synthetic cannabinoid use in a psychiatric patient population: a pilot study
- Synthetic cannabinoid JWH-018 and psychosis: An explorative study
- The utility of a new point-of-care test for synthetic cannabinoids: a mixed-methods study in people who use synthetic cannabinoids and stakeholders
- Synthetic cannabinoids in Europe
- The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'
- Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings
- Adding Spice to the Porridge: The development of a synthetic cannabinoid market in an English prison